Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Caux

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Bulletin Du Cancer|January 20, 2020
[Research evolutions in immuno-oncology and their impact on the management of patients treated with immunotherapy]Christophe Caux
Immunity|November 16, 2005
Critical role of ITIM-bearing FcgammaR on DCs in the capture and presentation of native antigen to B cellsBertrand Dubois, Christophe Caux
Targeted Oncology|February 22, 2012
Recent successes of cancer immunotherapy: a new dimension in personalized medicine?Christophe Caux, Laurence Zitvogel
Blood|December 1, 2012
Immunobiology. Combined targeted and immunotherapy: the future of personalized medicineAurélien Marabelle, Christophe Caux
Bulletin Du Cancer|December 18, 2021
[CAR-T cells and bispecific antibodies: An update on these major therapeutic advances]Jacques-Olivier Bay, Christophe Caux
Bulletin Du Cancer|January 29, 2019
Christophe Caux, Jacques-Olivier Bay
Bulletin Du Cancer|January 1, 2019
Christophe Caux, Jacques-Olivier Bay
Cytokine & Growth Factor Reviews|March 20, 2002
Chemokines in cancerAlain P Vicari, Christophe Caux
Medecine Sciences : M/S|January 7, 2020
[The biology of PD1 and CTLA-4 as immunotherapeutic targets and the issue of biomarkers]Marie-Caroline Dieu-Nosjean, Christophe Caux
Cancer Immunology Research|July 8, 2022
Direct T-cell Presentation by cDC1: The Key Feature for Cancer Vaccine Success?Margaux Hubert, Christophe Caux, Jenny Valladeau-Guilemond
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Bulletin Du Cancer|January 20, 2020
[Research evolutions in immuno-oncology and their impact on the management of patients treated with immunotherapy]Christophe Caux
Immunity|November 16, 2005
Critical role of ITIM-bearing FcgammaR on DCs in the capture and presentation of native antigen to B cellsBertrand Dubois, Christophe Caux
Targeted Oncology|February 22, 2012
Recent successes of cancer immunotherapy: a new dimension in personalized medicine?Christophe Caux, Laurence Zitvogel
Blood|December 1, 2012
Immunobiology. Combined targeted and immunotherapy: the future of personalized medicineAurélien Marabelle, Christophe Caux
Bulletin Du Cancer|December 18, 2021
[CAR-T cells and bispecific antibodies: An update on these major therapeutic advances]Jacques-Olivier Bay, Christophe Caux
Bulletin Du Cancer|January 29, 2019
Christophe Caux, Jacques-Olivier Bay
Bulletin Du Cancer|January 1, 2019
Christophe Caux, Jacques-Olivier Bay
Cytokine & Growth Factor Reviews|March 20, 2002
Chemokines in cancerAlain P Vicari, Christophe Caux
Medecine Sciences : M/S|January 7, 2020
[The biology of PD1 and CTLA-4 as immunotherapeutic targets and the issue of biomarkers]Marie-Caroline Dieu-Nosjean, Christophe Caux
Cancer Immunology Research|July 8, 2022
Direct T-cell Presentation by cDC1: The Key Feature for Cancer Vaccine Success?Margaux Hubert, Christophe Caux, Jenny Valladeau-Guilemond
Pageof 15